FLAG-Ida regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: IDA-FLAG Regimen; Idarubicin-Fludarabine-AraC/G-CSF Regimen
Overview
Overview
FLAG-Ida regimen refers to idarubicin, fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.[1]
Regimen
Regimen
IDAIdarubicin
FLFludarabine
ACytarabine (AraC)
GFilgrastim (G-CSF)
References
References
- ↑ 1.0 1.1 Parker JE, Pagliuca A, Mijovic A, Cullis JO, Czepulkowski B, Rassam SM; et al. (1997). “Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia”. Br J Haematol. 99 (4): 939–44. PMID 9432047.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH